Lung Cancer
Volume 66, Issue 3 , Pages 287-291 , December 2009

Significant association between EGFR-mutated lung adenocarcinoma and past illness from gastric cancer or uterine myoma: Its implication in carcinogenesis

  • Koji Okudela

      Affiliations

    • Department of Pathology, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, 236-0004, Yokohama, Japan
    • ,
  • Tetsukan Woo

      Affiliations

    • Department of Surgery, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, 236-0004, Yokohama, Japan
    • ,
  • Takuya Yazawa

      Affiliations

    • Department of Pathology, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, 236-0004, Yokohama, Japan
    • ,
  • Nobuo Ogawa

      Affiliations

    • Division of Surgery, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, 6-16-1, Tomioka-higashi, Kanazawa-ku, 230-0051, Yokohama, Japan
    • ,
  • Michihiko Tajiri

      Affiliations

    • Division of Surgery, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, 6-16-1, Tomioka-higashi, Kanazawa-ku, 230-0051, Yokohama, Japan
    • ,
  • Munetaka Masuda

      Affiliations

    • Department of Surgery, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, 236-0004, Yokohama, Japan
    • ,
  • Hitoshi Kitamura

      Affiliations

    • Department of Pathology, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, 236-0004, Yokohama, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 45 787 2583; fax: +81 45 789 0588.

Received 1 October 2008 ,Revised 8 February 2009 ,Accepted 12 February 2009.

References 

  1. In:  Travis WD,  Brambilla E,  Muller-Hermelink EK,  Harris CC editor. World health organization classification of tumors. Pathology and genetics of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004;
  2. Kitamuran H, Kameda Y, Ito T, Hayashi H. Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol. 2000;113:610–620
  3. Gazdar AF, Shigematsu H, Herz J, Minna JD. Mutation and addiction to EGFR: the Achilles ‘heal’ of lung cancer?. Trends Mol Med. 2004;10:481–486
  4. Hede K. Lung cancer may be different for men and women, but researchers ponder what to do?. J Natl Cancer Inst. 2007;99:1830–1832
  5. Pao W, Wang TY, Riely GJ, Miller VA, Pan Q, Ladanyi M, et al. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLOS Medn. 2005;2:57–61
  6. Mounawar M, Mukeria A, Le Calvezn F, Hung RJ, Renard H, Cortot A, et al. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history. Cancer Res. 2007;67:5667–5672
  7. Suzuki M, Shigematsu H, Iizasa T, Hiroshima K, Nakatani Y, Minna JD, et al. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of non-small cell lung cancer. Cancer. 2006;106:2200–2207
  8. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res. 2004;64:8919–8923
  9. Tam IY, Chung LP, Suen WS, Wang E, Wong MC, Ho KK, et al. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res. 2006;12:1647–1653
  10. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, et al. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA. 2004;101:13306–13311
  11. Ahrendt SA, Decker PA, Alawi EA, Zhu Yr YR, Sanchez-Cespedes M, Yang SC, et al. Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer. 2001;92:1525–1530
  12. Echiburú-Chau C, Calaf GM. Rat lung cancer induced by malathion and estrogen. Int J Oncol. 2008;33:603–611
  13. Matsuo K, Ito H, Yatabe Y, Hiraki A, Hirose K, Wakai K, et al. Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese. Cancer Sci. 2007;98:96–101
  14. Bell DW, Brannigan BW, Matsuo K, Finkelstein DM, Sordella R, Settleman J, et al. Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms. Clin Cancer Res. 2008;14:4079–4084
  15. Okudela K, Hayashi H, Ito T, Yazawa T, Suzuki T, Nakane Y, et al. K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma. Am J Pathol. 2004;164:91–100
  16. Ward R, Hawkins N, O’Grady R, Sheehan C, O’Connor T, Impey H, et al. Restriction endonuclease-mediated selective polymerase chain reaction. Am J Pathol. 1998;153:373–379
  17. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;150:2129–2139
  18. Mah V, Seligson DB, Li A, Márquez DC, Wistuba II, Elshimali Y, et al. Aromatase expression predicts survival in women with early-stage non-small cell lung cancer. Cancer Res. 2007;67:10484–10490
  19. Elliott AM, Hannaford PC. Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners’ Oral Contraception Study. Contraception. 2006;73:331–335
  20. Kitaoka H. Sex hormone dependency in diffuse carcinoma of the stomach and results of chemo-endocrine therapy. Gan No Rinsho. 1984;30:741–748
  21. Hosoya Y, Kitoh Y, Kobayashi E, Okabe R, Fujimura A, Kanazawa K. Combination effects of tamoxifen plus 5-fluorouracil on gastric cancer cell lines in vitro. Cancer Lett. 1999;140:139–143
  22. Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 2008;44:2397–2403
  23. Wilking N, Isaksson E, von-Schoultz E. Tamoxifen and secondary tumours. An update. Drug Safe. 1997;16:104–117
  24. Sellers WR, Meyerson M. EGFR gene mutations: a call for global×global views of cancer. J Natl Cancer Inst. 2005;97:326–328

PII: S0169-5002(09)00072-5

doi: 10.1016/j.lungcan.2009.02.025

Lung Cancer
Volume 66, Issue 3 , Pages 287-291 , December 2009

Article Tools

* Image Usage & Resolution